vs
Side-by-side financial comparison of AMERICAN SUPERCONDUCTOR CORP (AMSC) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $74.5M, roughly 1.1× AMERICAN SUPERCONDUCTOR CORP). AMERICAN SUPERCONDUCTOR CORP runs the higher net margin — 158.1% vs 22.8%, a 135.3% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 21.4%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $2.4M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 33.2%).
Anglo American plc is a British multinational mining company with headquarters in London, England. It is the world's largest producer of platinum, representing approximately 40 percent of global output, as well as being a major producer of diamonds, copper, nickel, iron ore, polyhalite and steelmaking coal. The company has operations in Africa, Asia, Australia, Europe, North America and South America.
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
AMSC vs FDMT — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $74.5M | $85.1M |
| Net Profit | $117.8M | $19.4M |
| Gross Margin | 30.7% | — |
| Operating Margin | 4.5% | 17.3% |
| Net Margin | 158.1% | 22.8% |
| Revenue YoY | 21.4% | 8508900.0% |
| Net Profit YoY | 4679.1% | 139.1% |
| EPS (diluted) | $2.62 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $74.5M | $85.1M | ||
| Q3 25 | $65.9M | $90.0K | ||
| Q2 25 | $72.4M | $15.0K | ||
| Q1 25 | $66.7M | $14.0K | ||
| Q4 24 | $61.4M | $1.0K | ||
| Q3 24 | $54.5M | $3.0K | ||
| Q2 24 | $40.3M | $5.0K | ||
| Q1 24 | $42.0M | $28.0K |
| Q4 25 | $117.8M | $19.4M | ||
| Q3 25 | $4.8M | $-56.9M | ||
| Q2 25 | $6.7M | $-54.7M | ||
| Q1 25 | $1.2M | $-48.0M | ||
| Q4 24 | $2.5M | — | ||
| Q3 24 | $4.9M | $-43.8M | ||
| Q2 24 | $-2.5M | $-35.0M | ||
| Q1 24 | $-1.6M | $-32.4M |
| Q4 25 | 30.7% | — | ||
| Q3 25 | 31.0% | — | ||
| Q2 25 | 33.8% | — | ||
| Q1 25 | 26.5% | — | ||
| Q4 24 | 26.6% | — | ||
| Q3 24 | 28.7% | — | ||
| Q2 24 | 30.3% | — | ||
| Q1 24 | 24.8% | — |
| Q4 25 | 4.5% | 17.3% | ||
| Q3 25 | 4.5% | -67983.3% | ||
| Q2 25 | 7.8% | -396373.3% | ||
| Q1 25 | 2.5% | -383007.1% | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | -1.4% | -1704400.0% | ||
| Q2 24 | -8.2% | -849120.0% | ||
| Q1 24 | -5.3% | -136200.0% |
| Q4 25 | 158.1% | 22.8% | ||
| Q3 25 | 7.2% | -63195.6% | ||
| Q2 25 | 9.3% | -364386.7% | ||
| Q1 25 | 1.8% | -342657.1% | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | 9.0% | -1461433.3% | ||
| Q2 24 | -6.3% | -699060.0% | ||
| Q1 24 | -3.8% | -115717.9% |
| Q4 25 | $2.62 | $0.43 | ||
| Q3 25 | $0.11 | $-1.01 | ||
| Q2 25 | $0.17 | $-0.98 | ||
| Q1 25 | $0.04 | $-0.86 | ||
| Q4 24 | $0.06 | — | ||
| Q3 24 | $0.13 | $-0.79 | ||
| Q2 24 | $-0.07 | $-0.63 | ||
| Q1 24 | $-0.03 | $-0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $141.1M | $402.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $536.8M | $505.7M |
| Total Assets | $719.5M | $566.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.1M | $402.7M | ||
| Q3 25 | $212.9M | $305.1M | ||
| Q2 25 | $207.9M | $293.2M | ||
| Q1 25 | $79.5M | $321.4M | ||
| Q4 24 | $75.2M | $424.9M | ||
| Q3 24 | $72.1M | $501.9M | ||
| Q2 24 | $93.5M | $541.9M | ||
| Q1 24 | $90.5M | $525.9M |
| Q4 25 | $536.8M | $505.7M | ||
| Q3 25 | $342.2M | $369.0M | ||
| Q2 25 | $333.1M | $420.9M | ||
| Q1 25 | $197.1M | $469.7M | ||
| Q4 24 | $192.7M | $510.6M | ||
| Q3 24 | $187.0M | $552.9M | ||
| Q2 24 | $143.3M | $588.3M | ||
| Q1 24 | $144.6M | $600.6M |
| Q4 25 | $719.5M | $566.7M | ||
| Q3 25 | $445.6M | $424.0M | ||
| Q2 25 | $452.8M | $473.6M | ||
| Q1 25 | $310.5M | $515.7M | ||
| Q4 24 | $310.3M | $560.4M | ||
| Q3 24 | $298.4M | $604.0M | ||
| Q2 24 | $240.1M | $620.1M | ||
| Q1 24 | $232.8M | $629.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.2M | $28.6M |
| Free Cash FlowOCF − Capex | $2.4M | $28.5M |
| FCF MarginFCF / Revenue | 3.2% | 33.5% |
| Capex IntensityCapex / Revenue | 1.2% | 0.1% |
| Cash ConversionOCF / Net Profit | 0.03× | 1.47× |
| TTM Free Cash FlowTrailing 4 quarters | $16.0M | $-109.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.2M | $28.6M | ||
| Q3 25 | $6.5M | $-46.5M | ||
| Q2 25 | $4.1M | $-43.4M | ||
| Q1 25 | $6.3M | $-47.8M | ||
| Q4 24 | $5.9M | $-134.6M | ||
| Q3 24 | $12.7M | $-29.4M | ||
| Q2 24 | $3.4M | $-30.2M | ||
| Q1 24 | $2.2M | $-29.1M |
| Q4 25 | $2.4M | $28.5M | ||
| Q3 25 | $5.1M | $-46.6M | ||
| Q2 25 | $3.3M | $-43.4M | ||
| Q1 25 | $5.3M | $-48.4M | ||
| Q4 24 | $5.3M | $-138.4M | ||
| Q3 24 | $12.1M | $-31.2M | ||
| Q2 24 | $3.1M | $-30.6M | ||
| Q1 24 | $1.9M | $-29.8M |
| Q4 25 | 3.2% | 33.5% | ||
| Q3 25 | 7.7% | -51765.6% | ||
| Q2 25 | 4.6% | -289620.0% | ||
| Q1 25 | 7.9% | -345635.7% | ||
| Q4 24 | 8.7% | -13837100.0% | ||
| Q3 24 | 22.3% | -1038966.7% | ||
| Q2 24 | 7.8% | -611840.0% | ||
| Q1 24 | 4.6% | -106421.4% |
| Q4 25 | 1.2% | 0.1% | ||
| Q3 25 | 2.1% | 101.1% | ||
| Q2 25 | 1.1% | 440.0% | ||
| Q1 25 | 1.6% | 4507.1% | ||
| Q4 24 | 0.9% | 378600.0% | ||
| Q3 24 | 1.1% | 59266.7% | ||
| Q2 24 | 0.7% | 6980.0% | ||
| Q1 24 | 0.7% | 2535.7% |
| Q4 25 | 0.03× | 1.47× | ||
| Q3 25 | 1.37× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 5.22× | — | ||
| Q4 24 | 2.38× | — | ||
| Q3 24 | 2.60× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMSC
| Equipment And Systems | $56.0M | 75% |
| Megatran | $14.1M | 19% |
| Comtrafo Industria De Transformadores Eletricos SA | $4.6M | 6% |
FDMT
Segment breakdown not available.
